4DMedical posts FY26 revenue growth as commercial deployment ramps up
4DMedical reports 21% FY26 revenue growth as CT:VQ gains commercial adoption, global regulatory approvals and major healthcare partnerships.
Market Cap $12.92M
!
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Announcements
Filter Results
| BHL | Notice of Annual General Meeting/Proxy Form | 12/04/18 | ||
| BHL | BHL announces commencement of Austral development | 28/03/18 | ||
| BHL | Appendix 4G & Corporate Governance Statement | 27/03/18 | ||
| BHL | Annual Report to shareholders FY2017 | 27/03/18 | ||
| BHL | BHL enters into Strategic Services Arrangement | PRICE SENSITIVE | 27/03/18 | |
| BHL | BHL Full Year Results FY2017 | 28/02/18 | ||
| BHL | Appendix 4E Preliminary Final Report | PRICE SENSITIVE | 28/02/18 | |
| BHL Notice of Annual General Meeting/Proxy Form | |||
| 12/04/18 | |||
| BHL BHL announces commencement of Austral development | |||
| 28/03/18 | |||
| BHL Appendix 4G & Corporate Governance Statement | |||
| 27/03/18 | |||
| BHL Annual Report to shareholders FY2017 | |||
| 27/03/18 | |||
| BHL BHL enters into Strategic Services Arrangement | |||
| 27/03/18 | PRICE SENSITIVE | ||
| BHL BHL Full Year Results FY2017 | |||
| 28/02/18 | |||
| BHL Appendix 4E Preliminary Final Report | |||
| 28/02/18 | PRICE SENSITIVE | ||